Phase 4 Liver Transplantation Clinical Trials
10 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–10 of 10 trials
Recruiting
Phase 4
Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)
Liver TransplantationImmunosuppression
University Hospital, Limoges162 enrolled18 locationsNCT06354179
Recruiting
Phase 4
HOPE Against Cancer Recurrence in HCC
HCCLiver TransplantationOncological Outcomes
Philipp Dutkowski220 enrolled37 locationsNCT06717919
Recruiting
Phase 4
Influence of Human Albumin Supplementation on Kidney Dysfunction After Liver Transplantation
Acute Kidney InjuryLiver Transplantation
Rennes University Hospital400 enrolled8 locationsNCT06535945
Recruiting
Phase 4
Reducing Pain With Methadone and Ketamine in Liver Transplant
Liver Transplantation
Lahey Clinic50 enrolled2 locationsNCT06868589
Recruiting
Phase 4
Insulin Therapy for Postreperfusion Hyperglycemia
Liver TransplantationHyperglycaemia (Diabetic)
Seoul National University Hospital20 enrolled1 locationNCT03152890
Recruiting
Phase 4
Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations
Liver TransplantationImmunosuppression
University of British Columbia124 enrolled1 locationNCT05089604
Completed
Phase 4
Haemodynamic Effects Of Intravenous Paracetamol In Patients With Chronic Liver Disease Undergoing Liver Transplantation: A Pilot Study
Liver TransplantationChronic Liver Disease
Austin Hospital24 enrolled1 locationACTRN12615001132538
Completed
Phase 4
Comparison of the WarmCloud and Under body Bair Hugger for maintaining core temperature during liver transplantation
Liver Transplantation
Austin Hospital30 enrolled1 locationACTRN12614000953639
Recruiting
Phase 4
Asses the safety and efficacy of switching to tenofovir and lamivudine therapy in patients who have been receiving Hepatitis B Immunoglobulin and lamivudine prophylasix post liver transplant.
prevent Hepatitis B virus re-infection following liver transplantation with the use of tenofovir and lamivudine, withdrawing HBIG.
Professor Peter Angus40 enrolled1 locationACTRN12611001236987
Completed
Phase 4
Prevention of Cytomegalovirus (CMV) disease in liver transplant patients: studies of antiviral prophylaxis and pre-emptive therapy.
CMV and liver transplantation
Austin Health100 enrolled1 locationACTRN12610000787088